Hostname: page-component-7bb8b95d7b-wpx69 Total loading time: 0 Render date: 2024-10-03T22:32:21.520Z Has data issue: false hasContentIssue false
  • English
  • Français

γ-Aminobutyric acid type A receptor binding affinity in the right inferior frontal gyrus at resting state predicts the performance of healthy elderly people in the visual sustained attention test

Published online by Cambridge University Press:  21 March 2018

Masato Kasagi Open the ORCID record for Masato Kasagi [Opens in a new window] ,
Tomokazu Motegi ,
Kosuke Narita ,
Kazuyuki Fujihara ,
Yusuke Suzuki ,
Minami Tagawa ,
Koichi Ujita ,
Hirotaka Shimada  and
Masato Fukuda
Masato Kasagi
Affiliation:
Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Tomokazu Motegi
Affiliation:
Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Kosuke Narita*
Affiliation:
Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada
Kazuyuki Fujihara
Affiliation:
Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Yusuke Suzuki
Affiliation:
Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Minami Tagawa
Affiliation:
Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Koichi Ujita
Affiliation:
Department of Radiology, Gunma University Hospital, Maebashi, Gunma, Japan
Hirotaka Shimada
Affiliation:
Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Masato Fukuda
Affiliation:
Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
*
Correspondence should be addressed to: Kosuke Narita, Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario K1Z 7K4, Canada. Phone: +1-613-722-6521 ext. 6870; Fax: +1-613-798-2982. Email: Kosuke.Narita@theroyal.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Although recent studies have suggested that the γ-aminobutyric acid type A (GABAA) receptor binding affinity can be a more sensitive marker of age-related neuronal loss than regional gray matter (GM) volume, knowledge about the relationship between decreased GABAA receptor binding affinity and cognitive decline during normal aging is still limited.

Methods:

Thirty-seven healthy elderly individuals (aged 50–77 years (mean, 64.5 ± 7.3 years); 15 males and 22 females) were enrolled in this study. We investigated the association of the performance of the healthy elderly in the attentional function test with regional GM volume, regional cerebral bold flow (rCBF), and GABAA receptor binding affinity in the resting state by structural magnetic resonance imaging (MRI), arterial spin labeling (ASL), and 123I-iomazenil (IMZ) SPECT, with the analysis focusing on the bilateral inferior frontal gyri.

Results:

The score of the rapid visual information processing (RVP) test, which is used to assess visual sustained attention, showed a positive correlation with GABAA receptor binding affinity in the right inferior frontal gyrus. No significant correlation was found between RVP test score and regional GM volume or rCBF.

Conclusion:

The findings of 123I-IMZ SPECT, but not those of structural MRI or ASL, suggest that a decreased GABAA receptor binding affinity can be a sensitive marker of cognitive impairment.

Keywords

right inferior frontal gyrusattentional function123I-iomazenil SPECTstructural MRIarterial spin labelinghealthy elderly
Type
Original Research Article
Information
International Psychogeriatrics , Volume 30 , Issue 9: Issue Theme: Quality of Care for Frail Older Adults , September 2018 , pp. 1385 - 1391
Copyright
Copyright © International Psychogeriatric Association 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J. and Robbins, T. W. (2003). Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nature Neuroscience, 6, 115–116.Google Scholar
Aron, A. R., Robbins, T. W. and Poldrack, R. A. (2014). Inhibition and the right inferior frontal cortex: one decade on. Trends in Cognitive Sciences, 18, 177–185.Google Scholar
Bakan, P. (1959). Extraversion-introversion and improvement in an auditory vigilance task. British Journal of Psychology, 50, 325–332.Google Scholar
Baudouin, A., Clarys, D., Vanneste, S. and Isingrini, M. (2009). Executive functioning and processing speed in age-related differences in memory: contribution of a coding task. Brain and Cognition, 71, 240–245.Google Scholar
Convit, A., Wolf, O. T., Tarshish, C. and De Leon, M. J. (2003). Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proceedings of the National Academy of Sciences of the United States of America, 100, 2019–2022.Google Scholar
Coull, J. T., Frith, C. D., Frackowiak, R. S. J. and Grasby, P. M. (1996). A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory. Neuropsychologia, 34, 1085–1095.Google Scholar
Dodds, C. M., Morein-Zamir, S. and Robbins, T. W. (2010). Dissociating inhibition, attention, and response control in the frontoparietal network using functional magnetic resonance imaging. Cerebral Cortex, 21, 1155–1165.Google Scholar
Hanyu, H. et al. (2012). Regional differences in cortical benzodiazepine receptors of Alzheimer, vascular, and mixed dementia patients. Journal of the Neurological Sciences, 323, 71–76.Google Scholar
Hayasaka, S. and Nichols, T. E. (2004). Combining voxel intensity and cluster extent with permutation test framework. NeuroImage, 23, 54–63.Google Scholar
He, J. et al. (2012). The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognition. American Journal of Neuroradiology, 33, 1797–1803.Google Scholar
Johnson, N. A. et al. (2006). Pattern of cerebral hypoperfusion in Alzheimer's disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. International Congress Series, 1290, 108–122.Google Scholar
Kaup, A. R., Mirzakhanian, H., Jeste, D. V. and Eyler, L. T. (2011). A review of the brain structure correlates of successful cognitive aging. The Journal of Neuropsychiatry and Clinical Neurosciences, 23, 6–15.Google Scholar
Killiany, R. et al. (2000). Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. American Neurological Association, 47, 430–439.Google Scholar
La Fougère, C. et al. (2011). Where in-vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET. NeuroImage, 56, 951–960.Google Scholar
Lassen, N. A. (1992). Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers. Journal of Cerebral Blood Flow & Metabolism, 12, 709–716.Google Scholar
Lawrence, N. S., Ross, T. J. and Stein, E. A. (2002). Cognitive mechanisms of nicotine on visual attention. Neuron, 36, 539–548.Google Scholar
Maldjian, J. A., Laurienti, P. J., Kraft, R. A. and Burdette, J. H. (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage, 19, 1233–1239.Google Scholar
Merhof, D. et al. (2011). Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls. Journal of Cerebral Blood Flow and Metabolism, 31, 371–383.Google Scholar
Nakagawara, J., Sperling, B. and Lassen, N. A. (1997). Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke, 28, 124–132.Google Scholar
Nasreddine, Z. S. et al. (2005). The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695–699.Google Scholar
Nelson, H. E. (1982). National Adult Reading Test (NART): For the Assessment of Premorbid Intelligence in Patients with Dementia: Test Manual. NFER-Nelson.Google Scholar
Oldfield, R. C. (1971). The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia, 9, 97–113.Google Scholar
Pakkenberg, B. and Gundersen, H. J. (1997). Neocortical neuron number in humans: effect of sex and age. The Journal of Comparative Neurology, 384, 312–320.Google Scholar
Pappatà, S. et al. (2010). SPECT imaging of GABAA/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment. European Journal of Nuclear Medicine and Molecular Imaging, 37, 1156–1163.Google Scholar
Park, D. C. and Reuter-Lorenz, P. (2009). The adaptive brain: aging and neurocognitive scaffolding. Annual Review of Psychology, 60, 173–196.Google Scholar
Pascual, B. et al. (2012). Decreased carbon-11-flumazenil binding in early Alzheimer's disease. Brain, 135, 2817–2825.Google Scholar
Ruan, Q., D'Onofrio, G., Sancarlo, D., Bao, Z., Greco, A. and Yu, Z. (2016). Potential neuroimaging biomarkers of pathologic brain changes in mild cognitive impairment and Alzheimer's disease: a systematic review. BMC Geriatrics, 16, 104.Google Scholar
Salat, D. H., Kaye, J. A. and Janowsky, J. S. (2002). Greater orbital prefrontal volume selectively predicts worse working memory performance in older adults. Cerebral Cortex, 12, 494–505.Google Scholar
Sowell, E. R., Peterson, B. S., Thompson, P. M., Welcome, S. E., Henkenius, A. L. and Toga, A. W. (2003). Mapping cortical change across the human life span. Nature Neuroscience, 6, 309–315.Google Scholar
Varrone, A., Soricelli, A., Postiglione, A. and Salvatore, M. (1999). Comparison between cortical distribution of I-123 iomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT. Clinical Nuclear Medicine, 24, 660–665.Google Scholar
Waldron-Perrine, B. and Axelrod, B. N. (2012). Determining an appropriate cutting score for indication of impairment on the Montreal cognitive assessment. International Journal of Geriatric Psychiatry, 27, 1189–1194.Google Scholar